ISDA

Deposition Date 2021-03-28

Release Date 2021-10-13

Last Version Date 2024-05-01

Entry Detail

PDB ID:

7O18

Keywords:

TRANSCRIPTION

Title:

N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH I-BET282

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.70 Å

R-Value Free:

0.21

R-Value Work:

0.16

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Bromodomain-containing protein 4
Gene (Uniprot):BRD4
Chain IDs:A (auth: AAA)
Chain Length:127
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:O60885 Pfam ID:PF00439

Ligand Molecules

EDO

UYK

Primary Citation

Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.

Jones, K.L, Beaumont, D.M, Bernard, S.G, Bit, R.A, Campbell, S.P, Chung, C.W, Cutler, L, Demont, E.H, Dennis, K, Gordon, L, Gray, J.R, Haase, M.V, Lewis, A.J, McCleary, S, Mitchell, D.J, Moore, S.M, Parr, N, Robb, O.J, Smithers, N, Soden, P.E, Suckling, C.J, Taylor, S, Walker, A.L, Watson, R.J, Prinjha, R.K.Show

J.Med.Chem. 64 12200 12227 (2021)

PMID: 34387088 DOI: 10.1021/acs.jmedchem.1c00855

Abstact

The functions of the bromodomain and extra terminal (BET) family of proteins have been implicated in a wide range of diseases, particularly in the oncology and immuno-inflammatory areas, and several inhibitors are under investigation in the clinic. To mitigate the risk of attrition of these compounds due to structurally related toxicity findings, additional molecules from distinct chemical series were required. Here we describe the structure- and property-based optimization of the in vivo tool molecule I-BET151 toward I-BET282E, a molecule with properties suitable for progression into clinical studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures